Thermo Fisher Scientific
Plainville, MA · Alachua, FL · Cambridge, MA
2 confirmed programs
· 2 sponsors
· Last scored 2026-03-15
82.1
Signal Score
✓ FDA Inspections (1)
✓ Clinical Trials (2)
✓ SEC Filings (13)
✓ Press (20)
Quick Facts: Thermo Fisher Scientific
- Signal Score
- 82.1/100 (as of 2026-03-15)
- Quality Compliance
- 80.0/100
- Headquarters
- Plainville, MA · Alachua, FL · Cambridge, MA
- Modalities
- AAV, Lentiviral, Plasmid, Adenoviral
- Active CGT Programs
- 2 confirmed from ClinicalTrials.gov across 2 sponsors
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CGT manufacturing intelligence platform
Signal Score & Pillar Breakdown
Quality Compliance
80.0
FDA Inspections1 on record
Warning Letters0
Last InspectionVoluntary Action Indicated (VAI) (2024-11-20)
Operations
87.7
2 active programs across 2 sponsors
Modalities: Adenoviral, Lentiviral, Plasmid DNA, AAV
2 programs in advanced phases (Phase 2/3)
Source: ClinicalTrials.gov
2 active programs across 2 sponsors · Modalities: Adenoviral, Lentiviral, Plasmid DNA, AAV · 2 programs in advanced phases (Phase 2/3)
Programs
2
Sponsors2
ModalitiesAAV, Lentiviral, Plasmid, Adenoviral
2 active programs across 2 sponsors
Modalities: Adenoviral, Lentiviral, Plasmid DNA, AAV
2 programs in advanced phases (Phase 2/3)
Source: ClinicalTrials.gov facility matching
Source: ClinicalTrials.gov · Retrieved Mar 20, 2026
Financial Stability
78.0
Publicly traded — financial transparency
Moderate CGT presence in SEC filings (10 mentions)
Source: SEC EDGAR, press monitoring
13 SEC filings with CGT mentions on record
SEC Filings13 with CGT mentions
Publicly traded — financial transparency
Moderate CGT presence in SEC filings (10 mentions)
Capacity
83.0
3 CGT manufacturing sites
Broad modality coverage (4 modalities)
2 facility investment mentions in SEC filings
Active facility expansion (2 articles)
Sites: Plainville, MA, Lexington, MA, Alachua, FL
Source: SEC EDGAR, press monitoring, company profiles
3 CGT manufacturing sites
StatusAvailable
3 CGT manufacturing sites
Broad modality coverage (4 modalities)
2 facility investment mentions in SEC filings
Active facility expansion (2 articles)
Sites: Plainville, MA, Lexington, MA, Alachua, FL
Recent Press20 articles
3 CGT manufacturing sites
Broad modality coverage (4 modalities)
2 facility investment mentions in SEC filings
Active facility expansion (2 articles)
FDA Inspection History
2024-11
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2024-11-20 | Saint Louis, Missouri | Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Mar 20, 2026
Clinical Activity 2 studies
NCT02340936
Clinical Trial to Determinate Dose, Security and Efficacy or Lenalidomide...
PHASE1/PHASE2
Completed
NCT00982111
First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell...
PHASE3
Completed
Source: ClinicalTrials.gov · Retrieved Mar 20, 2026
Financial Intelligence
"Amounts expected to occur thereafter generally relate to contract manufacturing, clinical research and extended warranty service agreements, which typically have durations of
three
to
five years
."
"Amounts expected to occur thereafter generally relate to contract manufacturing, clinical research and extended warranty service agreements, which typically have durations of
three
to
five years
."
"Amounts expected to occur thereafter generally relate to contract manufacturing, clinical research and extended warranty service agreements, which typically have durations of
three
to
five years
."
"Amounts expected to occur thereafter generally relate to contract manufacturing, clinical research and extended warranty service agreements, which typically have durations of
three
to
five years
."
"Amounts expected to occur thereafter generally relate to contract manufacturing, clinical research and extended warranty service agreements, which typically have durations of
three
to
five years
."
"Amounts expected to occur thereafter generally relate to contract manufacturing, clinical research and extended warranty service agreements, which typically have durations of
three
to
five years
."
"Amounts expected to occur thereafter generally relate to contract manufacturing, clinical research and extended warranty service agreements, which typically have durations of
three
to
five years
."
"Amounts expected to occur thereafter generally relate to contract manufacturing, clinical research and extended warranty service agreements, which typically have durations of
three
to
five years
."
Source: SEC EDGAR · Retrieved Mar 20, 2026
Recent News 20 articles
Thermo Fisher’s Moat Faces Margin Test as Cell & Gene Therapy Growth Accelerates - Bitget
Thermo Fisher’s Moat Faces Margin Test as Cell & Gene Therapy Growth Accelerates Bitget
Where is Trump going in Cincinnati? What to know about the 2 locations - Cincinnati Enquirer
Where is Trump going in Cincinnati? What to know about the 2 locations Cincinnati Enquirer
EXCLUSIVE: President Donald Trump speaks 1-on-1 with Local 12 during Cincinnati visit - The National News Desk
EXCLUSIVE: President Donald Trump speaks 1-on-1 with Local 12 during Cincinnati visit The National Desk
Thermo Fisher (TMO) Invests $2 Billion in U.S. Manufacturing - GuruFocus
Thermo Fisher (TMO) Invests $2 Billion in U.S. Manufacturing GuruFocus
What to know about the businesses Trump is visiting in Cincinnati - Cincinnati Enquirer
What to know about the businesses Trump is visiting in Cincinnati Cincinnati Enquirer
FDA reconsidering Capricor’s snubbed DMD cell therapy after 'lifting' rejection - Fierce Biotech
FDA reconsidering Capricor’s snubbed DMD cell therapy after 'lifting' rejection Fierce Biotech
Thermo Fisher Scientific opens new distribution centre in Meath - Silicon Republic
Thermo Fisher Scientific opens new distribution centre in Meath Silicon Republic
Pharmaceutical CDMO Market Set for Strong Growth to USD 293.6 - openPR.com
Pharmaceutical CDMO Market Set for Strong Growth to USD 293.6 openPR.com
Thermo Fisher Scientific opens new distribution centre in Ireland - Med-Tech Insights
Thermo Fisher Scientific opens new distribution centre in Ireland Med-Tech Insights
Thermo Fisher adds DXR3 SmartRaman+ for non-destructive, at-line Raman QC - R&D World
Thermo Fisher adds DXR3 SmartRaman+ for non-destructive, at-line Raman QC R&D World
Lithuania’s manufacturing shift: Teltonika, Thermo Fisher & Orlen lead high-tech growth - LRT
Lithuania’s manufacturing shift: Teltonika, Thermo Fisher & Orlen lead high-tech growth LRT
$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More - Yahoo Finance
$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More Yahoo Finance
$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More - Yahoo Finance UK
$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More Yahoo Finance UK
Activate Advanced Contamination Control Technology To Safeguard Your Cell Therapy - Pharmaceutical Online
Activate Advanced Contamination Control Technology To Safeguard Your Cell Therapy Pharmaceutical Online
Hot-Melt Extrusion and Downstream Processing - News-Medical
Hot-Melt Extrusion and Downstream Processing News-Medical
Thermo Fisher to Close Franklin, Mass. Site, Cut Up to 80 Jobs - Contract Pharma
Thermo Fisher to Close Franklin, Mass. Site, Cut Up to 80 Jobs Contract Pharma
Charles River to close cell therapy CDMO site, lay off 20 staffers - Fierce Biotech
Charles River to close Maryland CDMO site, lay off 20 staffers Fierce Biotech
Thermo Fisher trims Mass. head count with Franklin site closure - Fierce Pharma
Thermo Fisher trims Mass. head count with Franklin site closure Fierce Pharma
Thermo Fisher to lay off 100, close Franklin facility amid executive shakeup - Worcester Business Journal
Thermo Fisher to lay off 100, close Franklin facility amid executive shakeup Worcester Business Journal
Thermo Fisher to close Mass. facility, lay off over 100 workers - The Business Journals
Thermo Fisher to close Mass. facility, lay off over 100 workers The Business Journals
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in: